IBB Holdings Information

IBB is an equity ETF with a total of 251 individual holdings. The top holdings are Amgen stock at 8.63%, Vertex Pharmaceuticals at 7.91%, Gilead Sciences at 7.20%, Regeneron Pharmaceuticals at 6.08%, and argenx SE at 3.32%.

Total Holdings

251

Top 10 Percentage

45.96%

Asset Class

Equity

ETF Category

Health

Assets

10.16B

PE Ratio

24.03

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	8.63%	2,056,243
2	VRTX	Vertex Pharmaceuticals Incorporated	7.91%	1,547,388
3	GILD	Gilead Sciences, Inc.	7.20%	5,151,557
4	REGN	Regeneron Pharmaceuticals, Inc.	6.08%	748,481
5	ARGX	argenx SE	3.32%	385,385
6	NTRA	Natera, Inc.	3.17%	1,012,918
7	RVMD	Revolution Medicines, Inc.	2.91%	1,412,178
8	BIIB	Biogen Inc.	2.30%	1,085,641
9	ALNY	Alnylam Pharmaceuticals, Inc.	2.28%	986,199
10	ILMN	Illumina, Inc.	2.16%	1,119,336
11	ONC	BeOne Medicines AG	2.07%	590,554
12	INSM	Insmed Incorporated	1.99%	1,592,436
13	INCY	Incyte Corporation	1.78%	1,468,189
14	MRNA	Moderna, Inc.	1.72%	2,695,045
15	UTHR	United Therapeutics Corporation	1.54%	304,396
16	ROIV	Roivant Sciences Ltd.	1.40%	3,829,720
17	GMAB	Genmab A/S	1.25%	3,874,097
18	ASND	Ascendis Pharma A/S	1.15%	458,626
19	NBIX	Neurocrine Biosciences, Inc.	1.13%	732,774
20	BBIO	BridgeBio Pharma, Inc.	1.01%	1,254,069
21	CRL	Charles River Laboratories International, Inc.	1.00%	353,031
22	MEDP	Medpace Holdings, Inc.	1.00%	170,655
23	BMRN	BioMarin Pharmaceutical Inc.	0.96%	1,411,645
24	EXEL	Exelixis, Inc.	0.94%	1,806,713
25	HALO	Halozyme Therapeutics, Inc.	0.87%	870,766

Showing 25 of 251 holdings

Subscribe to see the full list

Activate Now

As of Aug 14, 2026